nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ACAT inhibitors: evolution from cholesterol-absorption inhibitors to antiatherosclerotic agents
|
Roth, Bruce D. |
|
1998 |
3 |
1 |
p. 19-25 7 p. |
artikel |
2 |
Combinatorial chemistry consortia for cost-effective drug discovery
|
Dalton, Colin |
|
1998 |
3 |
1 |
p. 1-2 2 p. |
artikel |
3 |
Electrical genes
|
Bradley, David |
|
1998 |
3 |
1 |
p. 9- 1 p. |
artikel |
4 |
Fast-track approaches to selecting discovery candidates for full development
|
Brayden, David |
|
1998 |
3 |
1 |
p. 6-7 2 p. |
artikel |
5 |
Monitor: molecules and profiles
|
Lloyd, Andrew W. |
|
1998 |
3 |
1 |
p. 43-46 4 p. |
artikel |
6 |
New approaches to anticancer drug design based on the inhibition of farnesyltransferase
|
Sebti, Saïd M. |
|
1998 |
3 |
1 |
p. 26-33 8 p. |
artikel |
7 |
Oligonucleotide synthesis as a tool in drug discovery research
|
Marshall, William S. |
|
1998 |
3 |
1 |
p. 34-42 9 p. |
artikel |
8 |
Rational therapeutics
|
Wallace, Robert W. |
|
1998 |
3 |
1 |
p. 4-5 2 p. |
artikel |
9 |
Redefining genomics
|
Grausz, J. David |
|
1998 |
3 |
1 |
p. 11-18 8 p. |
artikel |
10 |
Society for Biomolecular Screening — highlights
|
Fernandes, Prabhavathi B. |
|
1998 |
3 |
1 |
p. 7-9 3 p. |
artikel |